CHECKMATE GOVERNMENT RELATIONS

Lobbying for GSK · Pharmaceutical company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · $50,000.00 income · posted Jan 20, 2026

Lobbying activity 2

Health Issues

No current bills filed. Focused engagement with HHS regarding pharmaceutical technology.

Pharmacy

No current bills filed. Focused engagement with HHS regarding pharmaceutical technology.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.